Dementia is one of the most feared diagnoses of aging. It affects memory, reasoning, independence, and ultimately identity, touching not only those diagnosed but also families, caregivers, and entire health systems. For decades, scientists have searched for ways to prevent dementia or meaningfully slow its progression, yet progress has been frustratingly slow. Treatments have largely …
For most of human history, night was a period of natural darkness. The sun sank below the horizon, the stars emerged in a velvet sky, and the body followed an ancient script that had been written into our biology over millions of years. Today, however, very few of us ever experience a truly dark night. …
Memory goes beyond remembering names or faces. It weaves together our experiences and forms the fabric of our identity. In Alzheimer’s disease (AD), that thread frays. Neurons lose the ability to communicate effectively: synapses, those tiny junctions where one neuron talks to another degenerate, electrical rhythms go off-beat, and structures in the brain like the …
It begins as a quiet breach so small you’d never notice. Imagine the brain as a city behind high, guarded walls, with sentries carefully screening every visitor. For most of our lives, those gates stand firm, keeping harmful invaders out while letting life-sustaining nutrients in. But in Alzheimer’s disease, those defenses weaken. Tiny gaps form. …
Scientists have long debated the primary triggers of Alzheimer’s disease, often focusing on the physical damage observed in the brain rather than the instructions that built it. While researchers concentrated on clearing away sticky plaques, a specific genetic component was quietly influencing the majority of cases from the shadows. Recent analysis indicates that this overlooked …
Something unusual happened in a Japanese laboratory when mice with Alzheimer’s disease started remembering again. Scientists at the Okinawa Institute of Science and Technology have developed a synthetic peptide that reversed cognitive decline in mouse models of Alzheimer’s disease. No human trials have taken place yet, and years of testing remain before patients could access …